Appendix Cancer Pseudomyxoma Peritonei Research Foundation
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 209,957 | 227,605 | −17,648 | 9.1 | 0% |
| 2012 | 127,314 | 123,735 | 3,579 | 17.0 | 0% |
| 2013 | 180,448 | 121,566 | 58,882 | 23.1 | 0% |
| 2014 | 126,714 | 124,521 | 2,193 | 22.8 | 0% |
| 2015 | 146,506 | 135,384 | 11,122 | 22.0 | 0% |
| 2016 | 224,831 | 166,801 | 58,030 | 22.0 | 0% |
| 2017 | 269,230 | 191,120 | 78,110 | 24.1 | 0% |
| 2018 | 383,708 | 203,894 | 179,814 | 33.2 | 12% |
| 2019 | 306,812 | 241,250 | 65,562 | 31.3 | 21% |
| 2020 | 391,196 | 265,909 | 125,287 | 34.1 | 21% |
| 2021 | 864,315 | 158,294 | 706,021 | 111.2 | 41% |
| 2022 | 467,148 | 228,028 | 239,120 | 89.4 | 32% |
| 2023 | 591,795 | 238,992 | 352,803 | 103.2 | 26% |
In its most recent public year (2023), this organization brought in $352,803 more than it spent. Its reserves stood at about 103.2 months of spending, up from 9.1 in 2011. Staff pay was 26% of spending. $28,058 of its net assets are donor-restricted.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Appendix Cancer Pseudomyxoma Peritonei Research Foundation's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works